康龙化成（北京）新药技术股份有限公司（股票代码：03759）于2026年6月3日发布截至2026年5月31日的证券变动月报表。公告显示，公司法定/注册股本总额为人民币1,837,283,628元，较上月底无变动。
根据公告，康龙化成现有H股普通股359,977,887股，包括非库存股份352,714,587股与库存股7,263,300股，本月无新增发行或转让，余额保持不变；A股普通股则为1,477,305,741股，无库存股份。本月未发生额外的股份回购或注销行为，股本总数维持稳定。
在股权激励方面，公司于2022年和2023年先后通过了A股限制性股票激励计划，截至本月，仍分别剩余682,152股和910,946股预计可发行或由库存转让。此外，此前购回的7,263,300股H股权益已授权用于2025年H股奖励信托计划，用作对员工的奖励。
公司表示，当前已符合适用的公众持股量要求。本次报告由公司秘书麦宝文签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.